Safety of sentinel node biopsy in pregnant patients with breast cancer.
BACKGROUND
Lymphoscintigraphy (LS) and sentinel lymph node biopsy (SLNB) have typically been contraindicated for pregnant patients diagnosed with breast cancer because they are considered unsafe.


METHODS
Twenty-six premenopausal non-pregnant patients who were candidates for LS underwent peritumoral injection of approximately 12 MBq of 99mTc-HSA nanocolloids. Static [15 min and 16 h post-injection (p.i.)] and whole-body (16 h p.i.) scintigraphic images were acquired. Activity concentration in the urine (0-2, 2-4, 4-8, 8-16 h p.i.) was evaluated by a gamma-counter. Activity in the bloodstream was measured at 4 and 16 h p.i. Thermoluminescent dosimeters (TLD) were placed, before tracer injection, on the injection site, between injection site and epigastrium (two points), and on the epigastrium, umbilicus and hypogastrium, and were removed before surgery.


RESULTS
Scintigraphic images showed no radiotracer concentration except in the injection site and in the sentinel node. In all patients, the total activity excreted within the first 16 h was <2% of the injected activity. Activity in the blood pool was, at each time point, <1% of the injected activity. In 23 of 26 patients, all absorbed dose measurements were lower than the sensitivity of the TLD (<10 microGy); in the remaining three patients, the absorbed doses at the level of epigastrium, umbilicus and hypogastrium were in the following ranges: 40-320, 120-250 and 30-140 microGy, respectively.


CONCLUSIONS
According to our standard technique (12 MBq of 99mTc-HAS), LS and SLNB can be performed safely during pregnancy, since the very low prenatal doses from this diagnostic procedure, when properly performed, do not significantly increase the risk of prenatal death, malformation or mental impairment.
Division of Senology, Unit of Medical Physics, European Institute of Oncology, Milan, Italy.
O
O
Gentilini
M
M
Cremonesi
G
G
Trifirò
M
M
Ferrari
S M
SM
Baio
M
M
Caracciolo
A
A
Rossi
A
A
Smeets
V
V
Galimberti
A
A
Luini
G
G
Tosi
G
G
Paganelli
D000328:Adult; D001940:Breast / Q000000981:diagnostic imaging / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology; D011247:Pregnancy; D011829:Radiation Dosage; D021701:Sentinel Lymph Node Biopsy / Q000009:adverse effects / Q000379:methods*; D013819:Thermoluminescent Dosimetry; D013997:Time Factors; D014055:Tomography, Emission-Computed / Q000009:adverse effects / Q000379:methods*